000 01264 a2200337 4500
005 20250511202948.0
264 0 _c19920123
008 199201s 0 0 eng d
022 _a0161-5890
024 7 _a10.1016/0161-5890(91)90038-l
_2doi
040 _aNLM
_beng
_cNLM
100 1 _aSandlie, I
245 0 0 _aEngineering monoclonal antibodies to determine the structural requirements for complement activation and complement mediated lysis.
_h[electronic resource]
260 _bMolecular immunology
_cDec 1991
300 _a1361-8 p.
_bdigital
500 _aPublication Type: Journal Article; Research Support, Non-U.S. Gov't; Review
650 0 4 _aAmino Acid Sequence
650 0 4 _aAnimals
650 0 4 _aAntibodies, Monoclonal
_ximmunology
650 0 4 _aComplement Activation
_ximmunology
650 0 4 _aCytotoxicity, Immunologic
_xphysiology
650 0 4 _aHumans
650 0 4 _aImmunoglobulin G
_xgenetics
650 0 4 _aMice
650 0 4 _aMolecular Sequence Data
650 0 4 _aRestriction Mapping
650 0 4 _aSequence Homology, Nucleic Acid
700 1 _aMichaelsen, T E
773 0 _tMolecular immunology
_gvol. 28
_gno. 12
_gp. 1361-8
856 4 0 _uhttps://doi.org/10.1016/0161-5890(91)90038-l
_zAvailable from publisher's website
999 _c1755780
_d1755780